Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-18-000939
Filing Date
2018-01-26
Accepted
2018-01-26 16:16:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G sc13g0118a3brio_tapimmune.htm SC 13G/A 74623
  Complete submission text file 0001213900-18-000939.txt   76496
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
TAPIMMUNE INC. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-58217 | Film No.: 18552072
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570
Business Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570 516-536-0500
Brio Capital Master Fund Ltd. (Filed by) CIK: 0001560894 (see all company filings)

IRS No.: 981072321 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A